Blog Posts, Elder Law
alzheimer's Elder Law
The Food and Drug Administration (FDA) has approved a drug purported to slow the progress of Alzheimer’s disease. However, the decision is not without controversy. A recent article by AARP explores this subject in some detail. Here is a synopsis.
A New Treatment for Alzheimer’s Disease and the Controversy Surrounding It
Blog Posts, Elder Law
alzheimer's Elder Law
Excerpt
The Food and Drug Administration (FDA) has approved a drug purported to slow the progress of Alzheimer’s disease. However, the decision is not without controversy. A recent article by AARP explores this subject in some detail. Here is a synopsis.
- Version 1.0
- Download 17
- File Size 92.02 KB
- File Count 2
- Create Date July 21, 2021
- Last Updated July 21, 2021
Download Now